Aimei Health Technology Co., Ltd
Status: Live Deal
U=S+R
R=S/5
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Dec 4, 2023 |
| CEO | Mr. Junheng Xie |
| Left Lead | Spartan Capital |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 12 + 1 + 1 + (10*1) |
| IPO Sector |
Healthcare
Small cap companies domiciled in North America, Europe and/or the Asia Pacific regions that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space |
| IPO Geography | Global |
| Target Company | United Hydrogen Group Inc. |
| Deal Announced | Jun 20, 2024 |
| Deal Size, $M | $1,600.00M |
| Deal Sector | Energy |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Jan 31, 2025 |
AFJK
AFJKU
AFJKR
| Price | $10.75 |
|---|---|
| Last closing price | $10.76 |
| H/L, today | $10.74 / $10.80 |
| Volume, today | 310 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Aimei Health Technology Co., Ltd:
- Structure and cap table
- 5 directors & officers
- 16 filings and events
- 2 underwriters
- 1 deal advisors
- 5 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Mr. Junheng Xie | 35 | Chief Executive Officer, Secretary and Director |
| Heung Ming Wong | 54 | Chief Financial Officer and Director |
| Lin Bao | 49 | Director |
| Dr. Julianne Huh | 54 | Director |
| Robin Karlsen | 30 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Spartan Capital | BR | 5,950,000 | units |
| B. Riley FBR | 50,000 | ||
| 6,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
2.00 | % |
Sign in to view more advisor data.